https://www.live-feeds.com/feed/thyroid-tablets-recalled-nationwide-over-potential-superpotency-fdaContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/thyroid-tablets-recalled-nationwide-over-potential-superpotency-fdahttps://www.live-feeds.com/feed/thyroid-tablets-recalled-nationwide-over-potential-superpotency-fda#u50107Thu, 27 Aug 2026 13:01:07 +0000The FDA has announced a nationwide recall of thyroid tablets due to potential 'superpotency', which can lead to hyperthyroidism. The affected product is Vitruvias Therapeutics' Thyroid Tablets, USP 30 mg, specifically lot number 504950. The recall was issued as a precautionary measure to prevent adverse effects, particularly in elderly and pregnant patients.Why it mattersThe recall was issued due to concerns that the tablets may be 'superpotent', meaning they contain more active ingredients than stated, which can cause hyperthyroidism. Hyperthyroidism can lead to sympt